CFLAR and hepatocellular carcinoma: Previous results and our data (Supplemental figure 10) have shown that FLIP was constitutively expressed in Hep3B, HepG2, and Huh7 cells, which were reported to be TRAIL-resistant HCC cells [11, 26].